Alan Leshner

The Scientist Date: April 26, 1997 THE SCIENTIST® The Newspaper for the Life Sciences Professional (609)-786-7207 For Fast Service "It's obviously very important to stay up to date, and since I define my field broadly, THE SCIENTIST has the most comprehensive coverage of a wide range of topics. THE SCIENTIST is a good way to stay connected with policy, policymakers, and the general scientific community." ALAN LESHNER Director National Institute On Drug Abuse National Institutes Of Heal


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: April 26, 1997

ALAN LESHNER
Director
National Institute On Drug Abuse
National Institutes Of Health
Rockville, MD

By training, Leshner is a neuroscientist and psychologist. He has conducted research on the relationship between biology and behavior. And it is because of this research focus and the evolution of the neuroscience of drug abuse that his interest grew in that direction. By working with drug abuse professionals, the general public, and policymakers, Leshner is striving to ensure that the science supported by NIDA is not only useful but also used.

A reader of THE SCIENTIST, Leshner says: "It's obviously very important to stay up to date and since I define my field broadly, THE SCIENTIST has the most comprehensive coverage of a wide range of topics. THE SCIENTIST is a good way to stay connected with policy, policymakers, and the general scientific community."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo